Purification and assembling a fused capsid protein as an enterovirus 71 vaccine candidate from inclusion bodies to pentamer-based nanoparticles
Autor: | Zhiguo Su, Qi Wang, Chuan Qin, Ling Xue, Yongdong Liu, Jian Luo, Chun Zhang, Jiangning Liu, Jian Wang, Longfu Xu |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
chemistry.chemical_classification Environmental Engineering Chemistry Pentamer 030106 microbiology Size-exclusion chromatography Ion chromatography Biomedical Engineering Bioengineering Peptide Molecular biology Inclusion bodies 03 medical and health sciences Titer 030104 developmental biology Capsid Antigen Biotechnology |
Zdroj: | Biochemical Engineering Journal. 117:139-146 |
ISSN: | 1369-703X |
DOI: | 10.1016/j.bej.2016.10.009 |
Popis: | An efficient preparation process for a novel Enterovirus 71 (EV71) vaccine was developed in this paper, which is a fused antigen by connecting the truncated capsid proteins of VP1, VP2 and VP3 into one molecule through flexible peptide linkers and expressed in E. coli as inclusion bodies. The fused protein was purified at denatured state through two-step ion exchange chromatography, with final purity above 95%, host cell proteins below 0.003% and residual DNA less than 50 ng/mL. During the following refolding and assembling process through dilution, the fused antigen precipitated completely, while the precipitation was efficiently inhibited with 2 M urea or 0.5 M arginine as an additive. Size exclusion chromatography analysis indicated the protein formed soluble aggregates with linear or rod-like appearance in transmission electron microscopy. These aggregates transformed into pentamers with a size of 15 nm at pH 8.0 after the additive removing. Moreover, most of the pentamers assembled as sphere-like particulates about 25–40 nm after being induced by calcium chloride. High antigen-specific IgG titer was elicited by immunization with the nanoparticles in mouse model. Splenocytes proliferative responses and cytokines analysis indicated this particulate antigen could induce humoral and cellular immune responses. These results lay foundations for developing the fused antigen as an alternative vaccine against hand-foot-and-mouth disease (HFMD) and for the large-scale production for E.coli-based vaccines. |
Databáze: | OpenAIRE |
Externí odkaz: |